Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Acute Pancreatitis With Long-Term Celecoxib VS. Ibuprofen or Naproxen: Data From the PRECISION Trial

Yeomans, Neville D. MD, FACG1; Graham, David Y. MD, MACG2; Wang, Qiuqing MS3; Wolski, Kathy MPH3; Borer, Jeffrey MD4; Husni, Elaine M. MD, MPH3; Libby, Peter MD5; Lincoff, Michael A MD3; Lüscher, Thomas MD6; Wisniewski, Lisa M. RN3; Bao, Warren PhD7; Walker, Chris PhD8; Nissen, Steven E. MD3

American Journal of Gastroenterology: July 2018 - Volume 113 - Issue 7 - p 1053–1054
doi: 10.1038/s41395-018-0051-6

1University of Melbourne Department of Medicine, Austin Health, Melbourne, Victoria, and Western Sydney University, Campbelltown, NSW, Australia. 2Baylor College of Medicine, Veterans Affairs Medical Center, Houston, TX, USA. 3Cleveland Clinic, Cleveland, OH, USA. 4Downstate College of Medicine, State University of New York, New York, NY, USA. 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 6Royal Brompton and Harefield Hospital Trust and Imperial College, London, United Kingdom. 7Pfizer, New York, NY, USA. 8Pfizer Ltd, Tadworth, UK.

Correspondence: N.D.Y. (email:

© The American College of Gastroenterology 2018. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website